September 5, 2014

B2B2C or direct to consumer: Which telemedicine model will win?

Rob Coppedge, Cambia senior vice president of strategic investment and corporate development, shares his perspective on the telemedicine market.

Click here to read “B2B2C or direct to consumer: Which telemedicine model will win?” by MedCity News.

Related Reading

Cambia Promotes Rob Coppedge to President of Direct Health Solutions
Carena Secures Backing From Cambia Health and McKesson Ventures For Hospital System-Based Telemedicine Solutions
Health Insurers Urge CBO to consider non-Medicare Sources of Data in Scoring Congressional Telemedicine Proposals